The combination of AZD6234 with other incretin-based agents, such as the GLP-1/glucagon dual agonist AZD9550, is also being investigated in a phase 1 trial, with the planning for a phase 2 trial underway
Additionally, chronic liraglutide treatment protected synaptic plasticity impairments and, in contrast to fluoxetine, attenuated the inhibition of long-term potentiation in the hippocampus, which was induced by corticosterone in 30-day treatment [49]
A tan is pigment, not armor A darker look does not mean your skin is safe in the sun
With NIH colleagues, Raufman isolated and sequenced two peptides from the Gila monster venom
People with obesity tend to have a poorer response to some disease-modifying therapies, particularly older first-line treatments, compared with people at a healthier weight, she says